1,101 posts by 291 firms and lawyers
Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.
Dr. Marty Makary resigned as FDA commissioner last week, barely a year after his Senate confirmation. HHS Secretary Robert F. Kennedy Jr. confirmed the departure and indicated the agency is searching for a replacement.
” The general thrust is FDA’s assurance that it won’t interfere with a new federal initiative, which covers up to $500 of hemp-derived products for eligible Medicare patients.
In rapid succession, the federal government initiated two cannabis policy changes that, taken together, represent the most consequential realignment of the industry in more than half a century.
Seyfarth Synopsis: President Trump’s December 2025 Executive Order signals a possible shift in federal marijuana policy, but many employers still have a lawful and legitimate basis to prohibit impairment at work.
The recent federal policy shift, marked by Executive Order 14370: Increasing Medical Marijuana and Cannabidiol Research, reflects not only a legal development but also a broader cultural transformation.
Brett R. Friedman, Joshua Oyster, David Peloquin, Emily Fruchterman
January 12, 2026 By Edo Banach , Eli Greenspan , Matthew Piscitelli
S. Attorney General to reclassify cannabis from a Schedule I controlled substance to a Schedule III controlled substance under the Controlled Substances Act.
On December 18, 2025, President Donald Trump signed an Executive Order titled Increasing Medical Marijuana and Cannabidiol Research, marking the most consequential federal cannabis policy action in decades.
President Trump’s new Executive Order (EO) is historic, not only because it directs the rescheduling of cannabis from Schedule I to Schedule III, but because it also directs Congress to revise the “hemp ban” language in the 2026…
On December 18, President Trump issued an Administrative Order directing the Attorney General to complete the rulemaking process to reschedule marijuana from Schedule I to Schedule III under the federal Controlled Substances Act.
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that directs the Attorney General in the most expeditious manner in accordance with federal law, to…
On December 18, President Trump issued an executive order (EO) directing the Attorney General to complete rulemaking to reschedule “marijuana” from Schedule I to Schedule III under the Controlled Substances Act (CSA) and to…
President Donald Trump has issued an Executive Order (EO), “Increasing Medical Marijuana and Cannabidiol Research,” which directs federal agencies to 1) expedite the rescheduling of marijuana from Schedule I to Schedule III under…
On December 18, 2025, President Trump issued an executive order directing his administration to complete the process for reclassifying marijuana under the federal Controlled Substances Act, moving it from Schedule I to Schedule…
Are you not entertained? In a much-anticipated ceremony in the Oval Office, President Trump signed an executive order that (1) directs the attorney general to expeditiously reschedule marijuana to Schedule III and (2) instructs…
On December 18, 2025, President Donald Trump signed an executive order (the “Order”) directing the federal government to move cannabis from Schedule I to Schedule III under the federal Controlled Substances Act (“CSA”).
C. ” The announcement was made during an Oval Office meeting with Health and Human Services Secretary Kennedy, senior administration officials, doctors and veterans who advocate for increased access to medical cannabis.
Yesterday, the Trump Administration issued an Executive Order titled “Increasing Medical Marijuana and Cannabidiol Research” (the “EO”). It directs the Attorney General to expedite the rulemaking process related to rescheduling…
Yesterday, we saw President Trump issue an Executive Order instructing various government agencies to take steps to move marijuana from Schedule I (an illegal controlled substance with no medical uses and a high degree of…